Report cover image

Cell Line Development Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Sep 27, 2024
Length 141 Pages
SKU # PROD19315708

Description

Cell Line Development Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global cell line development market is expected to grow at a CAGR of around 10.1% during 2025-2034. This report on global cell line development market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cell line development market by segmenting the market based on product, source, application, end user, and region. Also, detailed profiles of companies operating in the cell line development market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rising Demand for Monoclonal Antibodies
• Growing Biopharmaceutical Industry

Market Challenges

• Strict Regulations

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

• Reagent and Media
• Equipment
• Finished Cells
• Other Products

Market by Source

• Mammalian Cell Line
• Non-mammalian Cell Line

Market by Application

• Recombinant Protein Expression
• Hybridomas Technology
• Vaccine Production
• Drug Discovery
• Other Applications

Market by End User

• Biotech and Pharmaceutical Companies
• Academics and Research Institutes
• Other End Users

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

141 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Cell Line Development Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Cell Line Development Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Cell Line Development Market by Product
5.1. Introduction
5.2. Reagent and Media
5.3. Equipment
5.4. Finished Cells
5.5. Other Products
6. Global Cell Line Development Market by Source
6.1. Introduction
6.2. Mammalian Cell Line
6.3. Non-mammalian Cell Line
7. Global Cell Line Development Market by Application
7.1. Introduction
7.2. Recombinant Protein Expression
7.3. Hybridomas Technology
7.4. Vaccine Production
7.5. Drug Discovery
7.6. Other Applications
8. Global Cell Line Development Market by End-User
8.1. Introduction
8.2. Biotech and Pharmaceutical Companies
8.3. Academics and Research Institutes
8.4. Other End Users
9. Global Cell Line Development Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. American Type Culture Collection (ATCC)
13.2.2. Corning Incorporated
13.2.3. Danaher Corporation
13.2.4. Fujifilm Corporation (Fujifilm Diosynth Biotechnologies)
13.2.5. Merck KGaA
13.2.6. Promega Corporation
13.2.7. Sartorius AG
13.2.8. Selexis SA
13.2.9. Thermo Fisher Scientific
13.2.10. WuXi Biologics
List of Figures
Figure 1: Global Cell Line Development Market (in US$ Million), 2020-2024
Figure 2: Global Cell Line Development Market by Product, 2024
Figure 3: Global Cell Line Development Market by Source, 2024
Figure 4: Global Cell Line Development Market by Application, 2024
Figure 5: Global Cell Line Development Market by End-User, 2024
Figure 6: Global Cell Line Development Market by Region, 2024
Figure 7: Global Cell Line Development Market by Technology, 2024
Figure 8: Global Cell Line Development Market (in US$ Million), 2025-2034
Figure 9: Global Cell Line Development Market by Product (in %), 2024 & 2034
Figure 10: Global Reagent and Media Cell Line Development Market (in US$ Million), 2020-2024
Figure 11: Global Reagent and Media Cell Line Development Market (in US$ Million), 2025-2034
Figure 12: Global Equipment Cell Line Development Market (in US$ Million), 2020-2024
Figure 13: Global Equipment Cell Line Development Market (in US$ Million), 2025-2034
Figure 14: Global Finished Cells Cell Line Development Market (in US$ Million), 2020-2024
Figure 15: Global Finished Cells Cell Line Development Market (in US$ Million), 2025-2034
Figure 16: Global Other Products Cell Line Development Market (in US$ Million), 2020-2024
Figure 17: Global Other Products Cell Line Development Market (in US$ Million), 2025-2034
Figure 18: Global Cell Line Development Market by Source (in %), 2024 & 2034
Figure 19: Global Mammalian Cell Line Cell Line Development Market (in US$ Million), 2020-2024
Figure 20: Global Mammalian Cell Line Cell Line Development Market (in US$ Million), 2025-2034
Figure 21: Global Non-mammalian Cell Line Cell Line Development Market (in US$ Million), 2020-2024
Figure 22: Global Non-mammalian Cell Line Cell Line Development Market (in US$ Million), 2025-2034
Figure 23: Global Cell Line Development Market by Application (in %), 2024 & 2034
Figure 24: Global Recombinant Protein Expression Cell Line Development Market (in US$ Million), 2020-2024
Figure 25: Global Recombinant Protein Expression Cell Line Development Market (in US$ Million), 2020-2034
Figure 26: Global Hybridomas Technology Cell Line Development Market (in US$ Million), 2020-2024
Figure 27: Global Hybridomas Technology Cell Line Development Market (in US$ Million), 2025-2034
Figure 28: Global Vaccine Production Cell Line Development Market (in US$ Million), 2020-2024
Figure 29: Global Vaccine Production Cell Line Development Market (in US$ Million), 2020-2034
Figure 30: Global Drug Discovery Cell Line Development Market (in US$ Million), 2020-2024
Figure 31: Global Drug Discovery Cell Line Development Market (in US$ Million), 2025-2034
Figure 32: Global Other Applications Cell Line Development Market (in US$ Million), 2020-2024
Figure 33: Global Other Applications Cell Line Development Market (in US$ Million), 2020-2034
Figure 34: Global Cell Line Development Market by End-User (in %), 2024 & 2034
Figure 35: Global Biotech and Pharmaceutical Companies Cell Line Development Market (in US$ Million), 2020-2024
Figure 36: Global Biotech and Pharmaceutical Companies Cell Line Development Market (in US$ Million), 2025-2034
Figure 37: Global Academics and Research Institutes Cell Line Development Market (in US$ Million), 2020-2024
Figure 38: Global Academics and Research Institutes Cell Line Development Market (in US$ Million), 2020-2034
Figure 39: Global Other End Users Cell Line Development Market (in US$ Million), 2020-2024
Figure 40: Global Other End Users Cell Line Development Market (in US$ Million), 2025-2034
Figure 41: Global Cell Line Development Market by Region (in %), 2024 & 2034
Figure 42: Europe Cell Line Development Market (in US$ Million), 2020-2024
Figure 43: Europe Cell Line Development Market (in US$ Million), 2025-2034
Figure 44: Europe Cell Line Development Market by Country (in %), 2024 & 2034
Figure 45: Germany Cell Line Development Market (in US$ Million), 2020-2034
Figure 46: United Kingdom Cell Line Development Market (in US$ Million), 2020-2034
Figure 47: France Cell Line Development Market (in US$ Million), 2020-2034
Figure 48: Italy Cell Line Development Market (in US$ Million), 2020-2034
Figure 49: Spain Cell Line Development Market (in US$ Million), 2020-2034
Figure 50: Russia Cell Line Development Market (in US$ Million), 2020-2034
Figure 51: Netherlands Cell Line Development Market (in US$ Million), 2020-2034
Figure 52: North America Cell Line Development Market (in US$ Million), 2020-2024
Figure 53: North America Cell Line Development Market (in US$ Million), 2025-2034
Figure 54: North America Cell Line Development Market by Country (in %), 2024 & 2034
Figure 55: United States Cell Line Development Market (in US$ Million), 2020-2034
Figure 56: Canada Cell Line Development Market (in US$ Million), 2020-2034
Figure 57: Asia Pacific Cell Line Development Market (in US$ Million), 2020-2024
Figure 58: Asia Pacific Cell Line Development Market (in US$ Million), 2025-2034
Figure 59: Asia Pacific Cell Line Development Market by Country (in %), 2024 & 2034
Figure 60: China Cell Line Development Market (in US$ Million), 2020-2034
Figure 61: Japan Cell Line Development Market (in US$ Million), 2020-2034
Figure 62: India Cell Line Development Market (in US$ Million), 2020-2034
Figure 63: South Korea Cell Line Development Market (in US$ Million), 2020-2034
Figure 64: Australia Cell Line Development Market (in US$ Million), 2020-2034
Figure 65: Indonesia Cell Line Development Market (in US$ Million), 2020-2034
Figure 66: Latin America Cell Line Development Market (in US$ Million), 2020-2024
Figure 67: Latin America Cell Line Development Market (in US$ Million), 2025-2034
Figure 68: Latin America Cell Line Development Market by Country (in %), 2024 & 2034
Figure 69: Mexico Cell Line Development Market (in US$ Million), 2020-2034
Figure 70: Brazil Cell Line Development Market (in US$ Million), 2020-2034
Figure 71: Argentina Cell Line Development Market (in US$ Million), 2020-2034
Figure 72: Middle East & Africa Cell Line Development Market (in US$ Million), 2020-2024
Figure 73: Middle East & Africa Cell Line Development Market (in US$ Million), 2025-2034
Figure 74: Middle East & Africa Cell Line Development Market by Country (in %), 2024 & 2034
Figure 75: Saudi Arabia Cell Line Development Market (in US$ Million), 2020-2034
Figure 76: Turkey Cell Line Development Market (in US$ Million), 2020-2034
Figure 77: Iran Cell Line Development Market (in US$ Million), 2020-2034
Figure 78: UAE Cell Line Development Market (in US$ Million), 2020-2034
Figure 79: Market Value Chain
List of Tables
Table 1: Global Cell Line Development Market Portraiture
Table 2: Global Cell Line Development Market by Product (in US$ Million), 2024 & 2034
Table 3: Global Cell Line Development Market by Source (in US$ Million), 2024 & 2034
Table 4: Global Cell Line Development Market by Application (in US$ Million), 2024 & 2034
Table 5: Global Cell Line Development Market by End-Use (in US$ Million), 2024 & 2034
Table 6: Global Cell Line Development Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Cell Line Development Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Cell Line Development Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Cell Line Development Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Cell Line Development Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Cell Line Development Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us